The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebul
Nebulized antibiotics for treating Ventilator-Associated Pneumonia | PPT
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Oral Inhaled Medications—Beyond Bronchodilators
Nebulized antibiotics for treating Ventilator-Associated Pneumonia | PPT
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
ARIKAYCE® (amikacin liposome inhalation suspension) | Official Patient Site
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Amikacin Liposome Dosage Guide + Max Dose, Adjustments - Drugs.com
Neonatal Intensive Care Unit Amikacin Dosage Protocol | Download Scientific Diagram
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Inhaled Amikacin Using AeroEclipse® XL BAN (Breath Actuated Nebulizer)
Amikacin injection or inhalation antibiotic uses, dose & side effects
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system | Critical Care | Full Text
Survey: Management of Arikayce-Associated Respiratory Adverse Events
Oral Inhaled Medications—Beyond Bronchodilators
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease | European Journal of Drug Metabolism and Pharmacokinetics
PDF) Pharmacokinetics of High Dose Nebulized Amikacin in Mechanically Ventilated Healthy Subjects.
Dosing | ARIKAYCE® (amikacin liposome inhalation suspension)
PDF) IN VITRO ASSESSMENT OF AEROSOLIZED AMIKACIN LUNG DOSE DELIVERED BY NKTR-061 PDDS CLINICAL DURING ON-VENTILATOR AND OFF-VENTILATOR USE
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
Drug as Percentage of Total Dose Deposited in Nebulizer and Ventilator... | Download Table
